Muhammet Özbilen

Dr. Muhammet Özbilen

Internal Medicine, Ordu University Faculty of Medicine, Ordu, Turkey (Türkiye)
+1
orcid
Iron deficiency

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AKAli Kirik
Ali Kirik
Hilmi Erdem SumbulHilmi Erdem Sumbul
Hilmi Erdem Sumbul
Nizameddin KocaNizameddin Koca
Nizameddin Koca
TKTurkan Pasali Kilit
Turkan Pasali Kilit
SSsibel demiral sezer
sibel demiral sezer
TDTeoman Doğru
Teoman Doğru
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence data in Türkiye is limited. We aimed to determine the nationwide prevalence of MASLD and advanced hepatic fibrosis risk in subjects with cardiometabolic risk factors (CMRF). Despite recent international consensus redefining fatty liver disease terminology, no nationwide MASLD study has been reported in Türkiye. Methods: This cross-sectional study included 14,371 adults with ≥1 CMRF from 44 centers across 31 cities. MASLD was diagnosed using liver ultrasonography plus cardiometabolic criteria. Advanced fibrosis risk was assessed by fibrosis-4 (FIB-4) score (≥1.3 for ≤65 years; ≥2.0 for >65 years). Logistic regression was used to identify independent predictors of high FIB-4. Results: A total of 61.4% of participants were women, the mean age was 51.3 ± 14.4 years, and the mean BMI was 31.4 ± 6.0 kg/m2. MASLD prevalence was 75.7% (n = 10,873), rising with the number of CMRFs (56.5% with one factor vs. 83.4% with all). The prevalence of high FIB-4 scores was 12.0% overall, being lower in MASLD patients than non-MASLD patients (11.2% vs. 14.4%, p < 0.001). FIB-4 scores decreased with increasing BMI (28.1% underweight vs. 8.7% class III obesity). Male sex, T2DM, and hypertension independently predicted high FIB-4 scores, while smoking, higher BMI, and MASLD were inversely associated. Conclusions: Three-quarters of Turkish adults with CMRF have MASLD. Standard FIB-4 thresholds may underestimate fibrosis risk in obese and smoking populations, underscoring the need for adjusted cut-offs or alternative tools. This study is the first to provide nationwide MASLD prevalence data in Türkiye.

1 November 2017 in Journal of Electrocardiology
Verified
Journal Article
Closed access
ABAdil Bayramoğlu
Adil Bayramoğlu
HTHakan Taşolar
Hakan Taşolar
OBOsman Bektaş
Osman Bektaş
MYMehmet Yaman
Mehmet Yaman
YKYasemin Kaya
Yasemin Kaya
AKAhmet Kaya
Ahmet Kaya


30 April 2019 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
SDSeçkin Dereli
Seçkin Dereli
ABAdil Bayramoğlu
Adil Bayramoğlu
NÖNurtaç Özer
Nurtaç Özer
SCSinan Cerşit
Sinan Cerşit
AKAhmet Kaya
Ahmet Kaya
Muhammet ÖzbilenMuhammet Özbilen
Muhammet Özbilen

28 July 2025 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
Muhammet ÖzbilenMuhammet Özbilen
Muhammet Özbilen
YKYasemin Kaya
Yasemin Kaya
Iron deficiency, the most widespread micronutrient deficiency globally, is especially common among women and seriously impacts their health considerably. The symptom spectrum in non-anemic iron deficiency (NAID) is less well described than in anemic forms. The aim of this study was to demonstrate the diversity and frequency of symptoms in NAID and compare with anemic cases and explore the association of symptoms with biomarkers. This retrospective and cross-sectional study was conducted on female patients at a university hospital. Patients admitted to the iron deficiency outpatient clinic between March 2021 and August 2022 were analyzed. Patients aged 18 years and older with iron deficiency (ferritin < 30 mcg/L) were included. Iron parameters, hemoglobin levels, and symptoms were included into the dataset, and these independent variables were compared between patient groups categorized as NAID and iron deficiency anemia (IDA). The study sample consisted of 239 patients. The frequencies of IDA and NAID were 70.3% (n = 168) and 29.7% (n = 71), respectively. Forty-one distinct symptoms or symptom groups were documented, ranging from neuropsychiatric to gastrointestinal manifestations. The mean number of symptoms per person was 16.5 (7.03). The top ten most common symptoms were weakness (87.03%), fatigue (82.43%), easy fatigability (78.66%), amnesia (72.38%), feeling cold (71.55%), alopecia (70.29%), cold intolerance (69.04%), sleep problems (66.53%), nervosity (63.18%), and cold foot (59.83%). The IDA group had more diverse symptoms than the NAID group (P <.05). Most of the forty-one symptoms or symptom groups were similar in frequency in the IDA and NAID groups. Only palpitations, cold intolerance, easy fatigability, and unclassifiable group differed between the groups (P <.05). The highest correlation between iron parameters and symptom diversity was transferrin saturation (TSAT) (r=-.229, P <.001). All but three of the positive symptoms showed TSAT levels below 8%. This study confirms that anemia is not a prerequisite for the majority of iron deficiency symptoms, which are common in non-anemic women. TSAT demonstrates a robust correlation, underscoring its potential as an early diagnostic biomarker. Clinicians must acknowledge various non-specific symptoms irrespective of anemia. Additional research is required to corroborate findings and investigate symptom mechanisms and treatments.

1 January 2023 in Van Medical Journal
Verified
Journal Article
Closed access
Muhammet ÖzbilenMuhammet Özbilen
Muhammet Özbilen
SYSamet Yeşil
Samet Yeşil
EDEsra Demir
Esra Demir